Edited by: Joyce Der, University of Health and Allied Sciences, Ghana
Reviewed by: Yousef Khader, Jordan University of Science and Technology, Jordan
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
In January 2021, the Gulf Health Council (GHC), established the Gulf Centre for Disease Prevention and Control (Gulf CDC) in Riyadh, marking a pivotal step in harmonizing health strategies, enhancing knowledge generation, and promoting evidence-based approaches to both communicable (CD) and non-communicable diseases (NCD). The Gulf CDC’s mission includes consolidating the region’s health information systems, crucial for monitoring disease burden and shaping effective public health policies. An initial assessment of public health surveillance systems across the Gulf Cooperation Council (GCC) member states was conducted by the Gulf CDC. This revealed strong national surveillance coverage of CDs but identified areas for improvement, particularly in data quality and representativeness. These findings informed the development of the Gulf CDC’s health information strategy and confirmed the need for a regional surveillance system. Prior to the introduction of this system, senior experts in this field from all GCC member states were surveyed and a consensus process launched to agree on the first steps. This led to the strategic selection of a small number of priority communicable and non-communicable diseases for the pilot phase of the system. The final agreed list of diseases and conditions for the pilot are the CDs: acute respiratory infection (ARI), endemic dengue, brucellosis, measles and pulmonary tuberculosis together with the NCDs: cancer (registry) and road traffic injuries. The initiative will showcase the potential benefits of regional collaboration to improve health outcomes and will ultimately also contribute to global health security efforts.
The Gulf Health Council (GHC), established nearly five decades ago by the Gulf Cooperation Council (GCC), has played a pivotal role in advancing public health across Gulf states (
Central to the Gulf CDC’s mission is the consolidation of the region’s health information systems, so important for monitoring disease burden, understanding health determinants, and developing effective public health policies. As a first step, the Gulf CDC assessed the GCC member states’ public health surveillance systems, utilizing the 2001 Guidelines for Evaluating Surveillance Systems from the US Centres for Disease Control and Prevention (CDC) (
A critical next step is agreement on the priority health and disease indicators for piloting the new Gulf CDC’s regional surveillance system. This process involved two surveys conducted among eighteen senior surveillance and data experts from all the GCC member states, followed by a consensus workshop in June 2023. The initial survey collected the opinions on a wide range of issues including the potential lists of CDs and NCDs to be included in the surveillance system.
Based on the findings of the first survey, the second survey produced a potential shortlist suitable for piloting the system, as well as their reporting frequency. The CDs proposed were COVID-19, seasonal influenza, dengue, malaria, measles, tuberculosis, and antimicrobial resistance (AMR). For NCDs, cancer and road traffic accidents were proposed due to the existing infrastructures, such as cancer registries, that could facilitate the piloting of the system. The survey also proposed several reporting frequencies—weekly, monthly, quarterly, and annually—depending on the disease and data needs.
The face-to-face workshop enabled real-time discussion and consensus-building between the national experts on the final selection for inclusion in the pilot. The dialogue on each aspect followed the results produced in real time by an audience response system where the experts could anonymously share their choices. Through these discussions, several strategic adjustments were made to the draft list identified earlier. Notably, AMR was excluded from the pilot phase due to the complexities associated with its surveillance, with brucellosis included instead, recognizing that the lower incidence will allow for a more manageable data load. Additionally, it was agreed that COVID-19 and seasonal influenza be reported under the broader category of Acute Respiratory Infections (ARI), which would also cover Middle East Respiratory Syndrome (MERS) and potentially Respiratory Syncytial Virus (RSV) infection.
Cancer was confirmed as the most suitable non-communicable disease for the pilot phase, owing to the well-established cancer registries across the member states, with annual reporting deemed adequate. Road traffic accidents were also accepted, despite some concern of the challenges of standardizing data across multiple sources. Regarding the frequency of reporting, the experts appropriately recommended that these should align with existing international reporting systems such as for WHO to minimize the burden of reporting (
Communicable and non-communicable diseases reportable to the Gulf CDC (2023–2025), phase one.
| Reported disease/events | Frequency of reporting | Case definition |
|---|---|---|
| Cancer registry data | Annually | Following IARC guidelines ( |
| Road traffic injuries data | Annually | To be defined |
| Acute Respiratory Infection (ARI) | Weekly | Aligned as far as possible with those used by WHO |
| Endemic dengue | Weekly | |
| Brucellosis | Annually | |
| Measles | Monthly | |
| Pulmonary tuberculosis | Annually |
The Gulf CDC’s initiative to create a regional surveillance system is a groundbreaking step forward in public health collaboration within the GCC. Aside from the valuable data generated, the system should foster greater collaboration and trust among the important stakeholders, such as health care providers, laboratories, public health agencies, and communities (
It is recognised that the way ahead is expected to present several challenges. During the consensus meeting, the experts raised data sharing, data quality, representativeness, timeliness, transparency, and trust in the system as their main concerns. Currently data standardisation is also an issue, and this needs to be tackled by developing a unified solid and reliable user-friendly platform for standardised reporting and data sharing. Such a platform/reporting system must take into consideration the limitations of the current national systems and their resources and be aligned with the WHO standards and data requirements, wherever possible. Finally, to reduce the strain on already overburdened national surveillance teams, the burden and cost of data collection, reporting, and analysis must be minimized by preventing duplication, inconsistency, and inefficiency.
Over all however this initiative not only has the potential to significantly improve health outcomes for millions in the Gulf region but by focusing on harmonizing surveillance efforts, leveraging advanced technologies, and enhancing regional integration, it will offer a blueprint for other global health agencies seeking to improve their disease monitoring and response mechanisms.
Moreover, the Gulf CDC is mindful of the importance of aligning regional surveillance systems with international standards, such as those set by the World Health Organization (WHO) (
By addressing the challenges related to data quality, timeliness, and transparency, and by harnessing the latest technological advancements, the Gulf CDC is positioned to create an effective and sustainable surveillance system. This initiative will not only strengthen the public health infrastructure of the GCC member states but also promotes the region as a leader in global health security.
SM: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – review & editing. LA: Validation, Writing – review & editing. AAH: Conceptualization, Validation, Writing – review & editing. AAG: Conceptualization, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing. AK: Methodology, Validation, Writing – review & editing. AA: Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Visualization, Writing – review & editing. NA: Methodology, Validation, Writing – review & editing. SA: Validation, Writing – review & editing. BA: Conceptualization, Validation, Writing – review & editing. PP: Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Writing – review & editing.
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.